Post BMT sFas Levels With or Without Severe aGVHD or Infections
| aGVHD Grade . | No Infection . | Infection . | ||||
|---|---|---|---|---|---|---|
| # . | Median . | 25%-75% . | # . | Median . | 25%-75% . | |
| 0-I | 261 | 1,174.9 | 851.1-1,621.8 | 103 | 1,148.2 | 776.2-1,737.8 |
| II-IV | 83 | 1,445.4 | 955.0-1,995.3 | 32 | 1,862.1 | 1,071.5-2,511.9 |
| aGVHD Grade . | No Infection . | Infection . | ||||
|---|---|---|---|---|---|---|
| # . | Median . | 25%-75% . | # . | Median . | 25%-75% . | |
| 0-I | 261 | 1,174.9 | 851.1-1,621.8 | 103 | 1,148.2 | 776.2-1,737.8 |
| II-IV | 83 | 1,445.4 | 955.0-1,995.3 | 32 | 1,862.1 | 1,071.5-2,511.9 |
In each group the number of post-BMT samples (#) and the quartiles (median, 25% percentile and 75% percentile in pg/mL) are given. Grade 0-I = no or mild aGVHD, grade II-IV = clinically relevant aGVHD. Infection comprises viral, bacterial, and fungal infections.